The JNK/cJUN pathway, downstream of MAP3K1, is a stress-associated pathway that has been implicated as a therapeutic escape mechanism in cancer cells.18 Thus, we first tested the effect of buparlisib on PIK3CAmut ER+ T47D breast cancer cells. The gene discussed is MAP3K1; the disease is cancer.